LIPO
Lipella Pharmaceuticals
LIPO
LIPO
Delisted
LIPO was delisted on the 18th of June, 2025.
4 hedge funds and large institutions have $82.5K invested in Lipella Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
4
Holders Change
-2
Holders Change %
-33.33%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$5.18K |
| 2 |
2
Wells Fargo
San Francisco,
California
|
$19 |
Top Sellers
| 1 |
TSS
1
Two Sigma Securities
New York
|
$0 |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$73.9K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$3.44K |
| 4 |
4
Fidelity Investments
Boston,
Massachusetts
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $73.9K | 34,520 | -2,554 | -7% |
|
|
2
UBS Group
Zurich,
Switzerland
| $5.18K | 2,421 | +1,608 | +198% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $3.44K | 1,606 | -612 | -28% |
|
|
4
Wells Fargo
San Francisco,
California
| $19 | 9 | +1 | +13% |
|
|
TSS
5
Two Sigma Securities
New York
| – | – | -13,137 | Closed |
|
|
6
Fidelity Investments
Boston,
Massachusetts
| – | – | -52 | Closed |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|